Main menu

NCM 2022: Native molecule whole genome sequencing of short fragment cfDNA and FFPE DNA


The Oxford Nanopore Technologies (ONT) sequencing platform is a promising tool in cancer diagnostics because it enables sequencing of DNA molecules of any length. Furthermore, nanopore sequencing can interrogate epigenetic methylation status without any template manipulation, making it valuable for rapid disease classification and sample stratification. Nanopore technology has been largely optimized for long-read sequencing. However, useful templates like cell-free DNA (cfDNA) and DNA derived from formalin-fixed paraffin embedded tissue (FFPE DNA) are highly fragmented.

Download the PDF

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag